Quantum-Si Inc has announced a significant achievement in the field of protein sequencing. The company has successfully demonstrated the detection of all 20 naturally occurring amino acids in its Proteus development program. This milestone is expected to enhance the company's capabilities in protein analysis and could set a new standard for the industry.
Founded in Branford, Connecticut, Quantum-Si Inc operates under the SIC classification of Measuring & Controlling Devices, NEC (3829). The company is listed on the Nasdaq under the ticker symbol QSI. Recent filings include a 10-Q on November 5, 2026, and an 8-K on the same date, among others.
According to the recent SEC filing, the company issued a press release on November 18, 2026, highlighting its achievement. The press release stated, “the Company has demonstrated detection of all 20 naturally occurring amino acids in its Proteus development program.” This accomplishment is seen as a crucial step towards establishing a benchmark for protein sequencing technologies.
This breakthrough in protein sequencing technology could have significant implications for various stakeholders, including researchers and companies in the proteomics sector. As Quantum-Si continues to innovate, it may influence competitors in the measuring and controlling devices industry to enhance their offerings.
Looking ahead, Quantum-Si is expected to incorporate the detection of all 20 amino acids into a developmental sequencing kit for use on Proteus instruments. The company plans to share additional data demonstrating continued improvements in Proteus performance and progress toward commercial launch. Details were not available in the SEC filing regarding specific timelines for these developments.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





